Literature DB >> 18842757

Malignant fibrous histiocytoma of the head and neck: CT and MR imaging findings.

S-W Park1, H-J Kim, J H Lee, Y-H Ko.   

Abstract

BACKGROUND AND
PURPOSE: Malignant fibrous histiocytoma (MFH) is uncommon in the head and neck. The purpose of this study was to investigate CT and MR imaging features of 13 cases of MFH of this area.
MATERIALS AND METHODS: Two head and neck radiologists, in consensus, retrospectively reviewed CT (n = 11) and MR (n = 9) images in 13 patients (9 men and 4 women; mean age, 45 years) with histologically proved MFH of the head and neck, paying attention to the location and extent, size, margin, internal architecture, and pattern and degree of enhancement of the lesion. We also investigated if there were any differences in signal-intensity characteristics on MR images, according to different histologic subtypes.
RESULTS: All lesions were seen as well-defined (n = 2) or ill-defined (n = 11), aggressive masses with a mean size of 4.9 cm. The tumors were primarily located in the sinonasal cavity in 6, the soft tissue of the face and neck in 5, the oral cavity in 1, and the orbital roof in 1. One lesion arose in the bones with background fibrous dysplasia. Twelve lesions invaded the adjacent soft tissues, and bone destruction was seen in 11 lesions. The attenuation, signal intensity, and enhancement pattern of the lesions were nonspecific except for those of myxoid MFH.
CONCLUSIONS: Although rare, MFH of the head and neck is an aggressive tumor that arises most commonly in the sinonasal tract and is frequently associated with soft-tissue invasion and bone destruction on CT and MR images.

Entities:  

Mesh:

Year:  2008        PMID: 18842757     DOI: 10.3174/ajnr.A1317

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

1.  Malignant fibrous histiocytoma of the mandible and the infratemporal fossa-A case report.

Authors:  Himani Joshi; Chinna Swamy Rayappa
Journal:  Int J Surg Case Rep       Date:  2011-04-05

Review 2.  Malignant fibrous histiocytoma/undifferentiated high-grade pleomorphic sarcoma of the maxillary sinus: report of a case and review of the literature.

Authors:  Drazsen Vuity; Sandor Bogdan; Katalin Csurgay; Zoltan Sapi; Zsolt Nemeth
Journal:  Pathol Oncol Res       Date:  2013-06-29       Impact factor: 3.201

3.  [Malignant fibrous histiocytoma].

Authors:  P Sertznig; M Megahed
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

4.  CT findings of pleomorphic hyalinizing angiectatic tumor (PHAT) of soft parts of the neck.

Authors:  Pingding Kuang
Journal:  Jpn J Radiol       Date:  2012-11-20       Impact factor: 2.374

5.  Malignant fibrous histiocytoma of maxillary sinus- a diagnostic challenge.

Authors:  Sunila Jain; Ramneet Kaur; Rakesh Koul
Journal:  Indian J Surg Oncol       Date:  2015-02-22

Review 6.  The Spindle Cell Neoplasms of the Oral Cavity.

Authors:  Thorakkal Shamim
Journal:  Iran J Pathol       Date:  2015

7.  Myxofibrosarcoma arising in the maxillary sinus: a case report with a review of the ultrastructural findings and differential diagnoses.

Authors:  Ernst J G Norval; Erich J Raubenheimer
Journal:  J Maxillofac Oral Surg       Date:  2011-07-27

8.  Computed tomography and magnetic resonance imaging findings of malignant fibrous histiocytoma of the head and neck.

Authors:  Jing Li; Zhi-Jun Geng; Xiao-Fei Lv; Xin-Ke Zhang; Chuan-Miao Xie
Journal:  Mol Clin Oncol       Date:  2016-03-09

9.  Pleomorphic spindle cell sarcoma (PSCS) formerly known as malignant fibrous histiocytoma (MFH): a complex malignant soft-tissue tumor.

Authors:  H J Mankin; F J Hornicek; T F DeLaney; D C Harmon; A L Schiller
Journal:  Musculoskelet Surg       Date:  2012-11-07

10.  Elucidating potentially significant genomic regions involved in the initiation and progression of undifferentiated pleomorphic sarcoma.

Authors:  Paul Kurywchak; Jeff Kiefer; Elizabeth Lenkiewicz; Lisa Evers; Tara Holley; Michael Barrett; Glen J Weiss
Journal:  Rare Tumors       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.